Task: Answer the MCQ question.
Question: Which drug exhibits a -22.245% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CC(C)Cn1c(N)c(C(=O)CSc2nc3ccccc3c(=O)n2CCCN2CCOCC2)c(=O)n(C)c1=O
(b) CC(C)Oc1ccccc1C1(c2ccccc2)NC(=O)NC1=O
(c) CCOc1ccc(-c2c(C(=O)N/N=C/c3sccc3C)nnn2-c2nonc2N)cc1
Answer: a. CC(C)Cn1c(N)c(C(=O)CSc2nc3ccccc3c(=O)n2CCCN2CCOCC2)c(=O)n(C)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)Cn1c(N)c(C(=O)CSc2nc3ccccc3c(=O)n2CCCN2CCOCC2)c(=O)n(C)c1=O
CC(C)Cn1c(N)c(C(=O)CSc2nc3ccccc3c(=O)n2CCCN2CCOCC2)c(=O)n(C)c1=O
6-amino-3-methyl-1-(2-methylpropyl)-5-[2-[3-(3-morpholin-4-ylpropyl)-4-oxoquinazolin-2-yl]sulfanylacetyl]pyrimidine-2,4-dione